6S1

3-[3-[4-(1-azanylcyclobutyl)phenyl]-5-phenyl-imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine


Toggle HydrogenToggle Labels

Chemical Component Summary

Name3-[3-[4-(1-azanylcyclobutyl)phenyl]-5-phenyl-imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine
Identifiers3-[3-[4-(1-azanylcyclobutyl)phenyl]-5-phenyl-imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine
FormulaC27 H24 N6
Molecular Weight432.52
TypeNON-POLYMER
Isomeric SMILESc1ccc(cc1)c2ccc3c(n2)n(c(n3)c4cccnc4N)c5ccc(cc5)C6(CCC6)N
InChIInChI=1S/C27H24N6/c28-24-21(8-4-17-30-24)25-32-23-14-13-22(18-6-2-1-3-7-18)31-26(23)33(25)20-11-9-19(10-12-20)27(29)15-5-16-27/h1-4,6-14,17H,5,15-16,29H2,(H2,28,30)
InChIKeyHNFMVVHMKGFCMB-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count57
Chiral Atom Count0
Bond Count62
Aromatic Bond Count28

Drug Info: DrugBank

DrugBank IDDB14982 
NameMiransertib
Groups investigational
DescriptionMiransertib is under investigation in clinical trial NCT01473095 (Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma).
Synonyms
  • ARQ 092
  • ARQ092
  • ARQ-092
  • Miransertib
  • 3-{3-[4-(1-aminocyclobutyl)phenyl]-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl}pyridin-2-amine
Categories
  • Amines
  • Pyridines
CAS number1313881-70-7

Related Resource References

Resource NameReference
PubChem 53262401
ChEMBL CHEMBL4297188